Star Health & Allied

₹450.6 29 | 6.9%

WEBSITE BSE:543412 NSE : STARHEALTH 16 May, 00:00

Market Cap ₹26455 Cr.

Stock P/E 31.3

P/B 3.8

Current Price ₹450.6

Book Value ₹ 119.6

Face Value 10

52W High ₹647.7

Dividend Yield 0%

52W Low ₹ 330.1

Edit Ratio

Star Health & Allied Research see more...

Overview Inc. Year: 2005Industry: Insurance

Star Health and Allied Insurance Company Limited presents medical insurance products. It offers retail health products to various consumer segments, consisting of individuals, families, college students, and senior citizens, as well as persons with pre-present medical situations across the middle-marketplace purchaser phase; and institution health insurance guidelines provide to employees of corporates, which includes SMEs via corporation medical insurance plans. The organization additionally affords personal accident and travel insurance. It distributes its products via individual agent, corporate agent banks, different corporate marketers, brokers and on-line channel companions comprising internet aggregators, in addition to directly to customers. As of September 30, 2021, the agency had 779 medical health insurance branches across 25 states and 5 union territories in India. Star Health and Allied Insurance Company Limited changed into integrated in 2005 and is totally based in Chennai, India.

Star Health & Allied Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Star Health & Allied Quarterly Results

#(Fig in Cr.)	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Net Sales	2867	2913	3044	3206	3294	3395	3520	3704	3800	3798
Other Income	207	220	250	258	285	296	297	355	348	290
Total Income	3074	3132	3294	3463	3579	3692	3817	4059	4148	4088
Total Expenditure	2793	2996	2909	3296	3191	3502	3391	3910	3861	4089
Operating Profit	282	136	384	167	388	190	426	149	287	-1
Interest	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	282	136	384	167	388	190	426	149	287	-1
Provision for Tax	71	34	97	42	98	47	107	38	72	-1
Profit After Tax	210	102	288	125	290	142	319	111	215	1
Adjustments	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	210	102	288	125	290	142	319	111	215	1
Adjusted Earnings Per Share	3.6	1.7	4.9	2.1	4.9	2.4	5.4	1.9	3.7	0

Star Health & Allied Profit & Loss

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Net Sales	675	1018	1514	1911	2740	3662	4684	4627	9809	11262	12938	14822
Other Income	43	42	63	62	89	115	170	251	480	501	641	1290
Total Income	718	1060	1577	1974	2828	3778	4854	4877	10289	11763	13579	16112
Total Expenditure	822	1207	1329	1877	2690	3548	4523	6358	11871	11057	12848	15251
Operating Profit	-105	-147	249	97	138	229	330	-1481	-1582	706	731	861
Interest	1	1	2	3	7	2	3	3	26	35	39	0
Depreciation	10	19	17	20	23	28	29	46	43	52	59	0
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	-93	-140	137	118	171	267	406	-1446	-1397	826	1129	861
Provision for Tax	0	0	0	0	1	84	143	-360	-356	208	284	216
Profit After Tax	-93	-140	137	118	170	183	263	-1086	-1041	619	845	646
Adjustments	0	0	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	-93	-140	137	118	170	183	263	-1086	-1041	619	845	646
Adjusted Earnings Per Share	-2.8	-3.9	3.5	2.6	3.7	4	5.4	-19.8	-18.1	10.6	14.4	11

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	15%	41%	29%	34%
Operating Profit CAGR	4%	0%	26%	0%
PAT CAGR	37%	0%	36%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	-18%	-13%	NA%	NA%
ROE Average	14%	0%	-4%	-3%
ROCE Average	18%	1%	-5%	-3%

Star Health & Allied Balance Sheet

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Shareholder's Funds	190	142	360	789	960	1493	1904	3500	4604	5434	6342
Minority's Interest	0	0	0	0	0	0	0	0	0	0	0
Borrowings	0	0	0	0	250	250	250	250	720	470	470
Other Non-Current Liabilities	517	751	792	1190	1683	2158	2623	5187	6229	7292	8478
Total Current Liabilities	158	210	238	278	537	914	1216	1564	1961	0	0
Total Liabilities	864	1102	1390	2257	3430	4815	5994	10501	13514	13196	15290
Fixed Assets	54	46	62	77	92	85	90	80	113	101	159
Other Non-Current Assets	358	514	810	1435	2169	3043	4309	7277	12154	13961	15849
Total Current Assets	453	542	518	745	1169	1687	1595	3144	1247	461	652
Total Assets	864	1102	1390	2257	3430	4815	5994	10501	13514	14523	16659

Star Health & Allied Cash Flow

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Opening Cash & Cash Equivalents	40	57	80	94	229	372	750	513	1599	378	288
Cash Flow from Operating Activities	77	147	126	321	557	776	647	890	56	1276	1310
Cash Flow from Investing Activities	-70	-216	-192	-497	-663	-731	-1006	-2418	-3786	-1097	-1177
Cash Flow from Financing Activities	9	92	81	310	249	333	122	2613	2509	-268	23
Net Cash Inflow / Outflow	16	24	14	134	143	379	-237	1086	-1221	-89	156
Closing Cash & Cash Equivalent	57	80	94	229	372	750	513	1599	378	288	445

Star Health & Allied Ratios

#	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Earnings Per Share (Rs)	0	0	0	0	0	0	0	-19.81	-18.08	10.63	14.44
CEPS(Rs)	-2.8	-3.87	3.53	2.59	3.73	4.03	5.37	-19.81	-18.08	10.63	14.44
DPS(Rs)	0	0	0	0	0	0	0	0	0	0	0
Book NAV/Share(Rs)	0	0	0	0	0	0	0	63.85	78.68	93.35	108.31
Core EBITDA Margin(%)	-21.78	-18.6	12.23	1.78	1.81	3.11	3.43	-37.43	-21.02	1.82	0.7
EBIT Margin(%)	-13.82	-13.76	9.02	6.17	6.25	7.29	8.67	-31.25	-14.24	7.34	8.72
Pre Tax Margin(%)	-13.82	-13.76	9.02	6.17	6.25	7.29	8.67	-31.25	-14.24	7.34	8.72
PAT Margin (%)	-13.82	-13.76	9.02	6.17	6.21	5.01	5.62	-23.47	-10.61	5.49	6.53
Cash Profit Margin (%)	-13.82	-13.76	9.02	6.17	6.21	5.01	5.62	-23.47	-10.61	5.49	6.53
ROA(%)	-40.32	-84.51	54.42	20.52	17.02	12.42	13.5	-36.81	-22.89	20.9	182.3
ROE(%)	-40.32	-84.51	54.42	20.52	19.46	17.45	17.28	-40.19	-25.93	12.42	14.36
ROCE(%)	-40.32	-84.51	54.42	20.52	17.13	20.52	22.91	-48.98	-31.04	14.83	17.76
Receivable days	0	0	0	0	0	0	0	0	0	0	0
Inventory Days	0	0	0	0	0	0	0	0	0	0	0
Payable days	0	0	0	0	0	0	0	0	0	0	0
PER(x)	0	0	0	0	0	0	0	0	0	48.76	37.62
Price/Book(x)	0	0	0	0	0	0	0	0	9.03	5.55	5.01
Dividend Yield(%)	0	0	0	0	0	0	0	0	0	0	0
EV/Net Sales(x)	0.18	0.03	0.08	0.07	-0.02	-0.12	-0.03	-0.29	4.19	2.69	2.46
EV/Core EBITDA(x)	-1.13	-0.23	0.46	1.29	-0.34	-1.91	-0.37	0.9	-25.95	42.95	43.52
Net Sales Growth(%)	32.11	50.72	48.72	26.26	43.33	33.68	27.9	-1.23	112.02	14.81	14.89
EBIT Growth(%)	25.71	-50.07	197.52	-13.64	45.16	56	52.09	-455.93	3.4	159.17	36.6
PAT Growth(%)	25.71	-50.07	197.52	-13.64	44.27	7.79	43.56	-512.34	4.15	159.44	36.6
EPS Growth(%)	0	0	0	0	0	0	0	-469.12	8.72	158.81	35.76
Debt/Equity(x)	0	0	0	0	0	0	0	0	0.16	0.09	0.07
Current Ratio(x)	0.67	0.56	0.5	0.51	0.53	0.54	0.42	0.47	0.15	0.06	0.08
Quick Ratio(x)	0.67	0.56	0.5	0.51	0.53	0.54	0.42	0.47	0.15	0.06	0.08
Interest Cover(x)	0	0	0	0	0	0	0	0	0	0	0
Total Debt/Mcap(x)	0	0	0	0	0	0	0	0	0.02	0.02	0.01

Star Health & Allied Shareholding Pattern

#	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Promoter	58.28	58.28	58.25	58.02	57.94	57.92	57.9	57.69	57.68	57.67
FII	35.52	35.24	33.1	30.63	31	26.57	21.58	17.65	17.51	18.68
DII	1.26	1.44	3.08	6.12	6.11	11.14	15.11	17.05	16.43	15.43
Public	4.94	5.04	5.57	5.23	4.96	4.36	5.41	7.61	8.38	8.21
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Promoter	33.9	33.9	33.9	33.9	33.9	33.9	33.9	33.9	33.9	33.9
FII	20.66	20.5	19.26	17.9	18.14	15.55	12.64	10.37	10.29	10.98
DII	0.73	0.84	1.79	3.58	3.57	6.52	8.85	10.02	9.65	9.07
Public	2.87	2.93	3.24	3.06	2.9	2.55	3.17	4.47	4.92	4.83
Others	0	0	0	0	0	0	0	0	0	0
Total	58.17	58.17	58.2	58.43	58.51	58.53	58.55	58.76	58.77	58.78

Pros

Company has delivered good profit growth of 35% CAGR over last 5 years
Company is almost debt free.

Cons

Company has a low return on equity of 0% over the last 3 years.
Stock is trading at 3.8 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.